MedPath

Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care

Not Applicable
Completed
Conditions
Dyspnea
Interventions
Behavioral: Shortness of breath recognition and treatment
Registration Number
NCT02441868
Lead Sponsor
Wayne State University
Brief Summary

This study is a pilot test of an intervention to train family caregivers of home hospice patients about recognizing and treating shortness of breath.

Detailed Description

Shortness of breath is a prevalent symptom causing distress among patients at the end of life. In home hospice care family caregivers are expected to assist their family member with symptom management. This is often accomplished with little or no training.

The investigators have developed a bundle of training materials targeted for family caregivers of home hospice patients at risk for shortness of breath. The investigators will pilot test the intervention in this clinical trial. A future randomized clinical trial is planned and the evidence from this pilot will enhance the planning of that future trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Patient in home hospice care with an estimated survival of 3-4 weeks, at risk for dyspnea secondary to lung cancer, COPD, or heart failure.
  • Family caregiver in patient's home must speak and read English.
Exclusion Criteria
  • Patients with bulbar ALS or quadriplegia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InterventionShortness of breath recognition and treatmentall participants will receive the training
Primary Outcome Measures
NameTimeMethod
Change in patient respiratory comfortBaseline and up to four weeks until patient death

The Respiratory Distress Observation Scale will be used to measure patient respiratory comfort at enrollment (baseline), twice each week during the study until patient death.

Secondary Outcome Measures
NameTimeMethod
Family caregiver burden indexBaseline and participants will be followed for an average of 4 weeks until date of death

The Modified Caregiver Strain Index

Trial Locations

Locations (1)

Angela Hospice

🇺🇸

Livonia, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath